Copyright: ©Author(s) 2026.
World J Transl Med. Nov 28, 2026; 12(4): 127250
Published online Nov 28, 2026. doi: 10.5528/wjtm.127250
Published online Nov 28, 2026. doi: 10.5528/wjtm.127250
Figure 1 Iron-inflammation-erythropoiesis control of fibroblast growth factor 23 production and processing.
Iron deficiency, inflammation, and erythropoietic stress increase fibroblast growth factor 23 production, whereas proteolytic processing determines the balance between intact fibroblast growth factor 23 and C-terminal fragments. FGF23: Fibroblast growth factor 23; HIF: Hypoxia-inducible factor; IL-6: Interleukin-6; TNFα: Tumor necrosis factor alpha; EPO: Ery thropoietin; FGFR4: Fibroblast growth factor receptor 4; HF: Heart failure.
- Citation: Donate-Correa J. Iron, inflammation, and fibroblast growth factor 23: Integrating molecular crosstalk, cardiovascular biology, and therapeutic perspectives. World J Transl Med 2026; 12(4): 127250
- URL: https://www.wjgnet.com/2220-6132/full/v12/i4/127250.htm
- DOI: https://dx.doi.org/10.5528/wjtm.127250